"Maker China" and Jiangsu Province Small and Medium Enterprise Innovation and Entrepreneurship Competition Medical Great Health Topics was successfully held in Lianyungang

From August 29th to 30th, the seventh "Maker China" and 2022 Jiangsu Small and Medium Enterprise Innovation and Entrepreneurship Competition Pharmaceutical Health Health was led by the Provincial Industry and Information Technology Department and the Provincial Department of Finance and the Municipal Industry and Information Technology Bureau. The special competition was successfully held in Lianyungang. The 48 high -quality pharmaceutical great health projects that stood out from the province's regional competition competition in the form of road shows were competed in the form of road shows, and in -depth discussions with experts on -site, injecting endogenous motivation for the high -quality development of the city's pharmaceutical industry.

Since its launch in 2013, the Jiangsu SME Innovation and Entrepreneurship Competition has been successfully held for nine sessions. It has achieved good results in creating an atmosphere, discovering talents, connecting resources, and creating ecology. The normalization of the competition has stimulated the enthusiasm of innovation and entrepreneurship in Jiangsu Province SMEs, and has become one of the important events to promote the development of innovation and entrepreneurship in the province.

As one of the strategic emerging industries of Lianyungang City's vigorous development, the pharmaceutical industry is also a pillar industry with great potential. The development and expansion of the pharmaceutical industry is of great significance to the realization of the high -quality development of the industrial economy of Lianyungang. In recent years, Lianyungang City has taken the construction of China Pharmaceutical Port as the starting point, and has formed many well -known companies such as Hengrui Pharmaceutical, Kangyuan Pharmaceutical, Haosen Pharmaceutical, and Zhengda Tianqing. The development pattern of diversified exploration in new pharmaceutical fields such as traditional Chinese medicine and preparations, medicinal packaging materials has already possessed more obvious technology and industrial advantages, which has driven the overall development of the entire industry chain. This time the Jiangsu Small and Medium Enterprise Innovation and Entrepreneurship Competition Medical Great Health Topics was held in Lianyungang, which highly fits the advantages of Lianyungang's local characteristic industries. During the event, the Municipal Financial Holdings Group made a special trip to the company to visit the core area of ​​China Pharmaceutical and Pharmaceutical and Pharmaceuticals, and inspected Lianyungang pharmaceutical industry culture, industrial characteristics, industrial carriers, industrial policies, industrial services, etc., and went deep into the provincial original chemical drug innovation center , He Morning Pharmaceutical and other pharmacies and ports settled in enterprises, visiting the development of industry development experience on the spot, and set up an effective establishment of exchanges and cooperation between enterprises in the provincial chain, deep analysis of experts and enterprises, and institutional support and assistance of enterprises. Connected platform.

This competition also invited Yin Wu, a professor and blog director of the School of Life Sciences of Nanjing University, Zhang Yichuan, deputy director of the Jiangsu Medical Device Inspection Institute, and a researcher -level senior engineer, and Meng Xiaoying, the investment director of Yida Capital Health Industry Investment Division, Universities, institutions, capital and other different perspectives conduct on -site comments. After fierce competition, 12 win -win companies successfully advanced to the finals. Among them, Youmai Biotechnology (Lianyungang) Co., Ltd., which is supported by Lianyungang Pharmaceutical Talent Venture Capital Fund, has won the second place in the pharmaceutical major health specialty competition with the research and development results of new double -specific antibodies. Zhao Yong, CEO of Youmai Bio, said that he will start with the platform of the competition and continue to chase the dream of entrepreneurial in the medical field with its industry leadership, technological forward -looking, and innovative breakthrough. Essence

(Even the state -owned asset Wang Xiaowei Bai Guangkuo)

Review: Pan Ruikai

Editor in charge: Yu Mengmeng

- END -